Research Makes Gains on Fibromyalgia
07 Sep 2017
Enigmatic disorder calls for an integrated approach
By Shannon BurgertIncreasing evidence points to a sort of misprocessing in the central nervous system. Normal sensory messages are essentially amplified and processed by the brain as pain.When he was married, Boulder resident Dave Harrison sometimes couldn’t sleep in the same room as his wife—his skin is so sensitive that the draft from a fan or open window puts him in agony. He sports suspenders because neither belts nor elastic waistbands are tolerable. Harrison, 79, is one of more than 5 million adults nationwide who suffer from fibromyalgia. Fibromyalgia is characterized by chronic widespread musculoskeletal pain, often accompanied by fatigue, insomnia, anxiety, mood disorders and mental fog—and plenty of additional side effects, like Harrison’s sensitivity to touch. The disorder has a higher incidence in women than men, a ratio as high as 9 to 1. Fibromyalgia is challenging to diagnose. It can be difficult to find a pattern in symptoms, symptoms overlap with other chronic conditions, and it can’t be confirmed or dismissed through a simple lab test. “It’s a diagnosis of exclusion,” says Megan Moon, D.C., BSN-RN, a chiropractor and director of Colorado Fibromyalgia Center in Lafayette. But researchers may have made a breakthrough. Scientists at CU Boulder’s Cognitive and Affective Control Laboratory have recently identified, through brain scans, neurological patterns that correlate with the hypersensitivity to pain that fibromyalgia patients suffer. Marina López-Solà, Ph.D., lead author on the study (now an assistant professor at Cincinnati Children’s Hospital Medical Center), says that the brain signatures may not only help with clinical diagnoses—at this point with 93-percent accuracy—but may also illuminate variances in brain activity to help physicians understand what’s driving the pain for a particular patient, enabling them to design individualized treatment. The MRI scans, still in the early phases of a validation process, probably won’t be available for clinical use for many years. Though the tool is not yet at her fingertips, Moon is hopeful about the possibilities the brain signatures may offer. “Anything that can give us a quicker diagnosis, a more specific diagnosis, is extremely exciting,” she says, adding that the tool might make it possible to categorize patients into subtypes.